5-Aminolevulinic Photodynamic Therapy Versus Carbon Dioxide Laser Therapy for Small Genital Warts: A Multicenter, Randomized, Open-Label Trial
Ping Tu,Haiyan Zhang,Heyi Zheng,Heng Gu,Jinhua Xu,Jining Tao,Hongwei Wang,Xuejun Zhu,Xiuli Wang
DOI: https://doi.org/10.1016/j.jaad.2019.07.073
IF: 15.487
2021-01-01
Journal of the American Academy of Dermatology
Abstract:To the Editor: 5-Aminolevulinic acid photodynamic therapy (ALA-PDT) has been reported as a better treatment of genital warts than carbon dioxide laser therapy (CO2-LT) for atraumatic and low recurrence rates of ALA-PDT.1Wang X.L. Wang H.W. Wang H.S. Xu S.Z. Liao K.H. Hillemanns P. Topical 5-aminolaevulinic acid-photodynamic therapy for the treatment of urethral condylomata acuminata.Br J Dermatol. 2004; 151: 880-885Crossref PubMed Scopus (112) Google Scholar However, most of the reports were based on clinical trials within a single center and with relatively small sample sizes. In this study, a multicenter, randomized, open-label trial was designed to evaluate the efficacy, recurrence rates, and the safety of ALA-PDT versus CO2-LT in patients with genital warts. Five centers participated in this trial, including Peking University First Hospital, Peking Union Medical College Hospital, Institute of Dermatology, Chinese Academy of Medical Sciences and Peking Union Medical College, Huashan Hospital of Fudan University, and Shanghai Skin Diseases Hospital. Of the 453 initially enrolled patients with genital warts, 331 and 111 in the ALA-PDT and CO2-LT groups, respectively, completed at most 3 ALA-PDT/CO2-LT cycle treatments and 12 weeks of follow-up. The baseline characteristics did not differ between the treatment arms. The study contained 505 warts in the ALA-PDT group and 195 warts in the CO2-LT group, of which 175 (34.65%) and 58 (29.74%) warts were located on the urethral orifice and up to 5 cm within the urethra in the ALA-PDT and CO2-LT groups, respectively. After the first and second treatments, the clearance rate of the ALA-PDT group was significantly lower than that of the CO2-LT group (P < .05). However, 1 week after the last treatment, there was no significant difference in the clearance rates, which were 98.42% (497/505) in the ALA-PDT group and 100% (195/195) in the CO2-LT group (P > .05). Overall, 325 and 111 patients were completely cured in the ALA-PDT and CO2-LT groups, respectively (Fig 1 and Table I). The recurrence rates of the ALA-PDT and CO2-LT groups were 10.77% (35/325) and 33.33% (37/111), respectively (P < .05). Among them, the recurrence rates of urethral genital warts in the 2 groups were 10.53% (14/133) and 36.36% (16/44), respectively (P < .05) (Table I).Table IGenital wart clearance rates and recurrence rates for the patients in the 2 groupsTypeGroupBefore treatment1 week after last treatmentFollow-upPatients, nWarts, nWarts cleared, n (total)Clearance rate, %∗Clearance rate = (number of warts cleared/total number of warts) × 100%.P valuePatients cured, nRecurrence, n (total)Recurrence rate, %†Recurrence rate = (number of patients with lesion recurrence/number of patients cured by treatment) × 100%.P valueUrethral genital wartsALA-PDT134175174 (175)99.43>.999913314 (133)10.53<.0001‡P < .05.CO2-LT445858 (58)1004416 (44)36.36TotalALA-PDT331505497 (505)98.42.114232535 (325)10.77<.0001‡P < .05.CO2-LT111195195 (195)10011137 (111)33.33ALA-PDT, 5-Aminolevulinic acid photodynamic therapy; CO2-LT, carbon dioxide laser therapy.∗ Clearance rate = (number of warts cleared/total number of warts) × 100%.† Recurrence rate = (number of patients with lesion recurrence/number of patients cured by treatment) × 100%.‡ P < .05. Open table in a new tab ALA-PDT, 5-Aminolevulinic acid photodynamic therapy; CO2-LT, carbon dioxide laser therapy. No severe adverse events or systemic adverse effects were observed in either group. All patients in the ALA-PDT group experienced varying degrees of discomfort, but it was better tolerated than CO2-LT (P < .05). In addition, the researchers' and patients' overall evaluations of the efficacy and safety were better in the ALA-PDT group than that in the CO2-LT group. The findings indicated that the recurrence rate with ALA-PDT was much lower than that with CO2 carbonization, which is consistent with findings of earlier studies.2Liang J. Lu X.N. Tang H. Zhang Z. Fan J. Xu J.H. Evaluation of photodynamic therapy using topical aminolevulinic acid hydrochloride in the treatment of condylomata acuminata: a comparative, randomized clinical trial.Photodermatol Photoimmunol Photomed. 2009; 25: 293-297Crossref PubMed Scopus (50) Google Scholar, 3Stefanaki I.M. Georgiou S. Themelis G.C. Vazgiouraki E.M. Tosca A.D. In vivo fluorescence kinetics and photodynamic therapy in condylomata acuminata.Br J Dermatol. 2003; 149: 972-976Crossref PubMed Scopus (58) Google Scholar, 4Nucci V. Torchia D. Cappugi P. Treatment of anogenital condylomata acuminata with topical photodynamic therapy: report of 14 cases and review.Int J Infect Dis. 2010; 14: e280-e282Abstract Full Text Full Text PDF PubMed Scopus (32) Google Scholar A clinical trial conducted by Wang et al5Wang H.W. Wang X.L. Zhang L.L. Guo M.X. Huang Z. Aminolevulinic acid (ALA)-assisted photodynamic diagnosis of subclinical and latent HPV infection of external genital region.Photodiagnosis Photodyn Ther. 2008; 5: 251-255Crossref PubMed Scopus (31) Google Scholar showed that an advantage of ALA-PDT is the potential to clear latent and subclinical human papillomavirus infection to reduce the recurrence rate. These results suggest that there may be an immune mechanism with PDT that does not occur when tissue is vaporized with a CO2 laser. In conclusion, ALA-PDT has similar efficacy but lower recurrence rates compared with those of CO2-LT for the treatment of genital warts. Because the treatment was better tolerated and caused no scars or urethral strictures, the results of this study have led to its adoption as one of many recommended treatments in China.